Pharmafile Logo
Pharmafocus logo
Advanced Search

immunotherapy

Showing 15 posts of 78 posts found.

shutterstock_360472550

Harnessing the power of the immune system

October 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …

Feature
astrazeneca-sign

AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC

October 9, 2017
Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer

AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …

News
roche

Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer

September 27, 2017
Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq

It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …

News
roche__tree

FDA locks down combo immunotherapy trials, Roche added to hold

September 19, 2017
Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq

The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …

News

Lilly’s Cyramza combo boasts strong results in bladder cancer

September 11, 2017
Research and Development, Sales and Marketing Eli Lilly, bladder cancer, cyramza, immunotherapy, pharma

Eli Lilly has announced new Phase 3 data at the European Society for Medical Oncology 2017 Congress which further add …

News
bms_4

BMS hit by clinical trial hold from FDA

September 7, 2017
Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, immunotherapy, opdivo, pharma, pharmaceutical

The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination …

News
shutterstock_212035546

Immunotherapy firm develops breakthrough method for robust bispecific antibody production

August 30, 2017
Research and Development antibodies, immunotherapy, merus, pharma, pharmaceuticals

A team of researchers at Dutch immunotherapy research firm Merus have developed an approach to efficiently manufacture bispecific antibodies which …

News
cancer-cell

Independent research may change the immunotherapy game

August 17, 2017
Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical

Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …

News

Takeda strikes partnership to develop single-drug cancer combo immunotherapies

August 14, 2017
Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …

News
shutterstock_87495637

Ending the era of $100,000 cancer drugs

August 11, 2017
Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …

News
cancer-vs-alzheimer-1080x810

Cancer Research UK partners with Biotecnol to deliver experimental solid tumour drug

August 10, 2017
Research and Development, Sales and Marketing Biotecnol, Cancer, Cancer Research UK, drugs, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …

News

AZ attempts to clear dust of Mystic trial with $8.5 billion MSD deal

July 27, 2017
Medical Communications, Sales and Marketing AstraZeneca, MSD, Merck, biotech, drugs, immunotherapy, mystic, pharma, pharmaceutical

It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …

News
celgene_1_02

Celgene plays catch up with $1.4 billion immunotherapy deal

July 7, 2017
Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1

Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …

News
merck_entrance

FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017
Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

News
shutterstock_273326141

American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

June 29, 2017
Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy

The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025